Silence Therapeutics has spoken up about its phase 1 polycythemia vera (PV) clinical trial, providing an early look at how its siRNA prospect may match up to rivals from Incyte and Takeda. PV patients ...
Longitudinal studies are a research jewel, shedding light on motor neurone disease, cot deaths, Alzheimer’s and more. Don’t let the security breach in China put you off joining one, says Guardian colu ...
Hosted on MSN
A new way of visualizing blood pressure data can help doctors better manage patients with hypertension
If a picture is worth a thousand words, how much is a graph worth? For doctors trying to determine whether a patient's blood pressure is within normal range, the answer may depend on the type of graph ...
Glucotrack, Inc. announced that it will present safety and performance data from its first-in-human trial of a long-term continuous blood glucose monitoring (CBGM) system at the 2025 International ...
This story is from The Pulse, a weekly health and science podcast. Find it on Apple Podcasts, Spotify, or wherever you get your podcasts. Bad advice. That’s what Jenny Ahlstrom felt like her ...
Numerous genetic studies have identified many risk variants for type 2 diabetes (T2D)—but which genes and proteins are actually involved in the disease mechanisms? An international team led by ...
Big data intelligence moves the blood collection system from scrambling during predictable crises, to building resilience through data-driven foresight. By Dr Relebohiseng Matubatuba, Lecturer and ...
No correlation between pulmonary artery pressure readings and actual blood volume as measured by BVA, illustrating the benefit of BVA for HF volume care. Challenges industry assumptions about pressure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results